These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23033167)

  • 1. [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].
    Pfeiffer B; Rigopoulos A; Seggewiß H
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2093-6. PubMed ID: 23033167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.
    Faber L; Seggewiss H; Ziemssen P; Gleichmann U
    Catheter Cardiovasc Interv; 1999 Aug; 47(4):462-6. PubMed ID: 10470478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
    Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.
    Faber L; Seggewiss H; Welge D; Fassbender D; Schmidt HK; Gleichmann U; Horstkotte D
    Eur J Echocardiogr; 2004 Oct; 5(5):347-55. PubMed ID: 15341870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
    Kurita T; Tsuchikane E; Tanaka N; Suzuki T
    Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
    Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Honek T
    Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A repeat alcohol septal ablation procedure for hypertrophic obstructive cardiomyopathy where the first septal branch arose from the intermediate (ramus) artery.
    Doran GC; Burns CM; Murdoch DJ; Incani A; Walters DL
    Heart Lung Circ; 2013 Dec; 22(12):1026-9. PubMed ID: 23706939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of selective myocardial contrast echocardiography in percutaneous transluminal septal myocardial ablation: a case report.
    Okayama H; Sumimoto T; Morioka N; Yamamoto K; Kawada H
    Jpn Circ J; 2001 Sep; 65(9):842-4. PubMed ID: 11548888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial septal branch assessment in hypertrophic obstructive cardiomyopathy: New echocardiographic contrast agent for alcohol septal ablation.
    Rigopoulos AG; Pfeiffer B; Seggewiss H
    Herz; 2014 Mar; 39(2):219-21. PubMed ID: 23588605
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
    Gross CM; Schulz-Menger J; Krämer J; Siegel I; Pilz B; Waigand J; Friedrich MG; Uhlich F; Dietz R
    J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Vermaete I; Dujardin K; Stammen F
    Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal branch selection in alcohol septal ablation.
    Toutouzas K; Karanasos A; Anastasakis A; Vavuranakis M; Seggewiss H; Stefanadis C; Rigopoulos A
    Int J Cardiol; 2011 Feb; 147(1):143-4. PubMed ID: 19910065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Tsuchikane E; Takeda Y; Kobayashi T; Yachiku K; Nasu K; Kobayashi Y; Matsumoto H; Awata N
    Circ J; 2003 Sep; 67(9):763-7. PubMed ID: 12939552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
    Veselka J; Procházková S; Duchonová R; Bolomová-Homolová I; Pálenícková J; Tesar D; Cervinka P; Honek T
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):231-5. PubMed ID: 15390343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
    Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
    J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and echocardiographic correlates of suitable septal perforators for alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Chan W; Williams L; Kotowycz MA; Woo A; Rakowski H; Schwartz L; Overgaard CB
    Can J Cardiol; 2014 Aug; 30(8):912-9. PubMed ID: 25064582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.